These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 15369428

  • 1. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
    Harris BN, West DS, Johnson J, Hong SH, Stowe CD.
    J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
    [Abstract] [Full Text] [Related]

  • 2. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT, Neill KK, Davis DA.
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [Abstract] [Full Text] [Related]

  • 3. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan.
    West DS, Johnson JT, Hong SH.
    J Manag Care Pharm; 2006 Apr; 12(1):25-32. PubMed ID: 16420105
    [Abstract] [Full Text] [Related]

  • 4. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada.
    Mabasa VH, Ma J.
    J Manag Care Pharm; 2006 Jun; 12(5):371-6. PubMed ID: 16792443
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A, Bacon T, Peterson M.
    J Manag Care Pharm; 2009 Jun; 15(1):42-54. PubMed ID: 19125549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacy benefit spending on oral chemotherapy drugs.
    Curtiss FR.
    J Manag Care Pharm; 2006 Sep; 12(7):570-7. PubMed ID: 16981802
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prescription drug costs and the generic dispensing ratio.
    Liberman JN, Roebuck MC.
    J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
    Johnsrud M, Lawson KA, Shepherd MD.
    J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.